Zykadia® (ceritinib) – New formulation approval
March 18, 2019 - The FDA approved Novartis’ Zykadia (ceritinib) tablets, for the treatment of adults with metastatic non-small cell lung cancer whose tumors are anaplastic lymphoma kinase-positive as detected by an FDA-approved test.
Download PDF
